The antimycobacterial activity of capreomycin.
D000995:Antitubercular Agents / Q000494:pharmacology*; D002207:Capreomycin / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D004352:Drug Resistance, Microbial; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D007677:Kidney Function Tests; D009161:Mycobacterium / Q000187:drug effects*; D009163:Mycobacterium bovis / Q000187:drug effects; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014756:Viomycin / Q000494:pharmacology
D000995:Antitubercular Agents; D002207:Capreomycin; D007612:Kanamycin; D014756:Viomycin